Arkolith/Insider Trading/AKTX/Form 4

Farag Kameel D.

Interim CFOAkari Therapeutics Plc (AKTX) · full profile →Form 4 · filed Dec 18, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 16, 2025Buy(P)25K$0.40$10K25K
Dec 16, 2025Buy(P)25K——25K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-028419) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML